BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koutroumpakis E, Ramos-Rivers C, Regueiro M, Hashash JG, Barrie A, Swoger J, Baidoo L, Schwartz M, Dunn MA, Koutroubakis IE, Binion DG. Association Between Long-Term Lipid Profiles and Disease Severity in a Large Cohort of Patients with Inflammatory Bowel Disease. Dig Dis Sci 2016;61:865-71. [PMID: 26514677 DOI: 10.1007/s10620-015-3932-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Lu J, Yu F, Huang J, Yu H, Li F, Le Z, Cheng Y, Zhang Q, Li G, Xie X, Tang H, Zhang J. Hypocholesterolemia and Inflammatory Biomarkers Act as Predictors of Severe Vitamin D Deficiency in Patients With Crohn’s Disease: A Clinical Analysis of 862 Patients in China. Front Nutr 2022;9:806887. [DOI: 10.3389/fnut.2022.806887] [Reference Citation Analysis]
2 Morishige R, Nakajima H, Yoshizawa K, Mahlich J, Sruamsiri R. Preferences Regarding Shared Decision-Making in Japanese Inflammatory Bowel Disease Patients. Adv Ther 2017;33:2242-56. [PMID: 27807816 DOI: 10.1007/s12325-016-0436-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
3 Guan S, Jia B, Chao K, Zhu X, Tang J, Li M, Wu L, Xing L, Liu K, Zhang L, Wang X, Gao X, Huang M. UPLC–QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis. J Proteome Res 2020;19:600-9. [DOI: 10.1021/acs.jproteome.9b00440] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
4 Tao Z, Qin Z. Can Statins Be Used in Patients with Inflammatory Bowel Disease Regularly? Inflamm Bowel Dis 2016;22:E28-9. [PMID: 27416048 DOI: 10.1097/MIB.0000000000000857] [Reference Citation Analysis]
5 Probert F, Walsh A, Jagielowicz M, Yeo T, Claridge TDW, Simmons A, Travis S, Anthony DC. Plasma Nuclear Magnetic Resonance Metabolomics Discriminates Between High and Low Endoscopic Activity and Predicts Progression in a Prospective Cohort of Patients With Ulcerative Colitis. J Crohns Colitis 2018;12:1326-37. [PMID: 30016408 DOI: 10.1093/ecco-jcc/jjy101] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
6 Zanoni P, Velagapudi S, Yalcinkaya M, Rohrer L, von Eckardstein A. Endocytosis of lipoproteins. Atherosclerosis 2018;275:273-95. [PMID: 29980055 DOI: 10.1016/j.atherosclerosis.2018.06.881] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
7 Anderson AJ, Click B, Ramos-Rivers C, Babichenko D, Koutroubakis IE, Hartman DJ, Hashash JG, Schwartz M, Swoger J, Barrie AM 3rd, Dunn MA, Regueiro M, Binion DG. Development of an Inflammatory Bowel Disease Research Registry Derived from Observational Electronic Health Record Data for Comprehensive Clinical Phenotyping. Dig Dis Sci. 2016;61:3236-3245. [PMID: 27619390 DOI: 10.1007/s10620-016-4278-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
8 Leung ET, Raboin MJ, McKelvey J, Graham A, Lewis A, Prongay K, Cohen AM, Vinson A. Modelling disease risk for amyloid A (AA) amyloidosis in non-human primates using machine learning. Amyloid 2019;26:139-47. [PMID: 31210531 DOI: 10.1080/13506129.2019.1625038] [Reference Citation Analysis]
9 Tefas C, Ciobanu L, Tanțău M, Moraru C, Socaciu C. The potential of metabolic and lipid profiling in inflammatory bowel diseases: A pilot study. Bosn J Basic Med Sci 2020;20:262-70. [PMID: 31368421 DOI: 10.17305/bjbms.2019.4235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Tien N, Wu T, Lin C, Wu C, Hsu C, Fang Y, Lim Y. Impact of Inflammatory Bowel Disease (IBD) and IBD Medications on Risk of Hyperlipidemia and in vitro Hepatic Lipogenic-Related Gene Expression: A Population-Based Cohort Study. Front Med 2022;9:910623. [DOI: 10.3389/fmed.2022.910623] [Reference Citation Analysis]
11 He Q. Cardiocerebral and peripheral vascular risks in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2019; 27(5): 341-346 [DOI: 10.11569/wcjd.v27.i5.341] [Reference Citation Analysis]
12 Scoville EA, Allaman MM, Brown CT, Motley AK, Horst SN, Williams CS, Koyama T, Zhao Z, Adams DW, Beaulieu DB, Schwartz DA, Wilson KT, Coburn LA. Alterations in lipid, amino acid, and energy metabolism distinguish Crohn’s disease from ulcerative colitis and control subjects by serum metabolomic profiling. Metabolomics 2018;14. [DOI: 10.1007/s11306-017-1311-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 9.4] [Reference Citation Analysis]
13 Dragasevic S, Stankovic B, Kotur N, Sokic-Milutinovic A, Milovanovic T, Lukic S, Milosavljevic T, Srzentic Drazilov S, Klaassen K, Pavlovic S, Popovic D. Metabolic Syndrome in Inflammatory Bowel Disease: Association with Genetic Markers of Obesity and Inflammation. Metab Syndr Relat Disord 2020;18:31-8. [PMID: 31750766 DOI: 10.1089/met.2019.0090] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
14 Aarestrup J, Jess T, Kobylecki CJ, Nordestgaard BG, Allin KH. Cardiovascular Risk Profile Among Patients With Inflammatory Bowel Disease: A Population-based Study of More Than 100 000 Individuals. J Crohns Colitis. 2019;13:319-323. [PMID: 30321330 DOI: 10.1093/ecco-jcc/jjy164] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
15 Koo BS, Baek SH, Kim G, Hwang EH, Oh H, Son Y, Lim KS, Kang P, Lee HY, Jeong KJ, Kim YH, Villinger F, Hong JJ. Idiopathic chronic diarrhea associated with dysbiosis in a captive cynomolgus macaque (Macaca fascicularis). J Med Primatol 2020;49:56-9. [PMID: 31642533 DOI: 10.1111/jmp.12447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Pippis EJ, Yacyshyn BR. Clinical and Mechanistic Characteristics of Current JAK Inhibitors in IBD. Inflamm Bowel Dis 2021;27:1674-83. [PMID: 33295611 DOI: 10.1093/ibd/izaa318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Testa G, Rossin D, Poli G, Biasi F, Leonarduzzi G. Implication of oxysterols in chronic inflammatory human diseases. Biochimie 2018;153:220-31. [DOI: 10.1016/j.biochi.2018.06.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
18 Khan F, Radovanovic A, Gojobori T, Kaur M. IBDDB: a manually curated and text-mining-enhanced database of genes involved in inflammatory bowel disease. Database (Oxford) 2021;2021:baab022. [PMID: 33929018 DOI: 10.1093/database/baab022] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Szczeklik K, Mach T, Cibor D, Owczarek D, Sapa J, Papież M, Pytko-Polończyk J, Krzyściak W. Correlation of Paraoxonase-1 with the Severity of Crohn's Disease. Molecules 2018;23:E2603. [PMID: 30314292 DOI: 10.3390/molecules23102603] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Wu X, Liu K, Wu Q, Wang M, Chen X, Li Y, Qian L, Li C, Dai G, Zhang Q, Mu G, Wu J, Shan Z. Biomarkers of Metabolomics in Inflammatory Bowel Disease and Damp-Heat Syndrome: A Preliminary Study. Evid Based Complement Alternat Med 2022;2022:3319646. [PMID: 35815273 DOI: 10.1155/2022/3319646] [Reference Citation Analysis]
21 Liu Z, Tang H, Liang H, Bai X, Zhang H, Yang H, Wang H, Wang L, Qian J. Dyslipidaemia Is Associated with Severe Disease Activity and Poor Prognosis in Ulcerative Colitis: A Retrospective Cohort Study in China. Nutrients 2022;14:3040. [DOI: 10.3390/nu14153040] [Reference Citation Analysis]
22 Sleutjes JAM, Roeters van Lennep JE, van der Woude CJ, de Vries AC. Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease: Effect of Different Drug Classes and Inflammation. Inflamm Bowel Dis 2022:izac100. [PMID: 35590447 DOI: 10.1093/ibd/izac100] [Reference Citation Analysis]
23 Wang L, Wang R, Wei GY, Wang SM, Du GH. Dihydrotanshinone attenuates chemotherapy-induced intestinal mucositis and alters fecal microbiota in mice. Biomed Pharmacother 2020;128:110262. [PMID: 32447214 DOI: 10.1016/j.biopha.2020.110262] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]